Unknown

Dataset Information

0

Lipid-Lowering Drug Use and Cancer Incidence and Mortality in the ARIC Study

ABSTRACT: Abstract

Background

Lipid-lowering drugs, particularly statins, are associated with reduced

SUBMITTER: Marrone M 

PROVIDER: S-EPMC8562700 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study.
| S-EPMC6289799 | biostudies-literature
Unknown Prostate cancer incidence and mortality among men using statins and non-statin lipid-lowering medications.
| S-EPMC6501826 | biostudies-literature
Unknown Cholesterol lowering drug use and breast cancer survival: the Multiethnic Cohort Study.
| S-EPMC8557195 | biostudies-literature
Unknown Consistent use of lipid lowering therapy in HIV infection is associated with low mortality.
| S-EPMC7866454 | biostudies-literature
Unknown Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies.
| S-EPMC8198905 | biostudies-literature
Unknown Diabetes mellitus and cancer incidence: the Atherosclerosis Risk in Communities (ARIC) cohort study.
| S-EPMC6582039 | biostudies-literature
Unknown Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study.
| S-EPMC8545796 | biostudies-literature
Unknown Relation of lipid gene scores to longitudinal trends in lipid levels and incidence of abnormal lipid levels among individuals of European ancestry: the Atherosclerosis Risk in Communities (ARIC) study.
| S-EPMC3288431 | biostudies-literature
Unknown Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization.
| S-EPMC7693098 | biostudies-literature
Unknown Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study.
| S-EPMC4340061 | biostudies-literature